CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2020	Mar. 31, 2019
REVENUES AND OTHER INCOME
Net sales		$ 6,410	$ 4,004
Interest, dividends and other income		34	78
Gain on sale of equity investments and other assets, net		7	7
Total		6,451	4,089
COSTS AND OTHER DEDUCTIONS
Oil and gas operating expense		1,046	645
Transportation and gathering expense		558	31
Chemical and midstream cost of sales		612	669
Purchased commodities		393	365
Selling, general and administrative		260	140
Other operating and non-operating expense		195	238
Depreciation, depletion and amortization		2,242	973
Asset impairments and other charges	[1]	1,803	0
Taxes other than on income		182	111
Anadarko acquisition-related costs		148	0
Exploration expense		37	36
Interest and debt expense, net		352	98
Total		7,828	3,306
Income (loss) before income taxes and other items		(1,377)	783
OTHER ITEMS
Losses on interest rate swaps and warrants, net		(585)	0
Income (loss) from equity investments		(133)	73
Total		(718)	73
Income (loss) from continuing operations before income taxes		(2,095)	856
Income tax benefit (expense)		82	(225)
Income (loss) from continuing operations		(2,013)	631
NET INCOME (LOSS)		(2,013)	631
Less: Preferred stock dividends		(219)	0
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS		$ (2,232)	$ 631
Income (loss) from continuing operations—basic (in usd per share)		$ (2.49)	$ 0.84
Net income (loss) attributable to common stockholders—basic (in usd per share)		(2.49)	0.84
Income (loss) from continuing operations—diluted (in usd per share)		(2.49)	0.84
Net income (loss) attributable to common stockholders—diluted (in usd per share)		(2.49)	0.84
DIVIDENDS PER COMMON SHARE (in usd per share)		$ 0.79	$ 0.78

[1] ^(a) Includes $1.2 billion of impairment related to the write-off of goodwill.